TRAIL-R1-targeted chimeric antigen receptor T cells exhibit dual antitumor effects
Yaru Nai a, 1, Li Dua, 1, Meiying Shenb, Tingting Lia, Jingjing Huanga, Xiaojian Hana, Feiyang Luoa, Da Pangb, Aishun Jina, *
a Chongqing Key Laboratory of Basic and Translational Research of Tumor Immunology, Chongqing Medical University, Chongqing 400016, China
b Department of Breast Surgery, Harbin Medical University Cancer Hospital, Harbin 150081, China
* Corresponding authors at: Chongqing Key Laboratory of Basic and Translational Research of Tumor Immunology, Chongqing Medical University, No.1 Medical College Road, Yuzhong District, Chongqing 400016, People’s Republic of China.
E-mail addresses : aishunjin@cqmu.edu.cn.
1 These authors contributed equally to this research.